109 related articles for article (PubMed ID: 16467679)
1. Effect of a novel octapeptide urokinase fragment, A6, on experimental choroidal neovascularization in the monkey.
Koh HJ; Freeman WR; Azen SP; Flaxel CJ; Labree LD; Cheng L; Wills M; Jones TR
Retina; 2006 Feb; 26(2):202-9. PubMed ID: 16467679
[TBL] [Abstract][Full Text] [Related]
2. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.
Krzystolik MG; Afshari MA; Adamis AP; Gaudreault J; Gragoudas ES; Michaud NA; Li W; Connolly E; O'Neill CA; Miller JW
Arch Ophthalmol; 2002 Mar; 120(3):338-46. PubMed ID: 11879138
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of choroidal neovascularization in rats by the urokinase-derived peptide A6.
Koh HJ; Bessho K; Cheng L; Bartsch DU; Jones TR; Bergeron-Lynn G; Freeman WR
Invest Ophthalmol Vis Sci; 2004 Feb; 45(2):635-40. PubMed ID: 14744908
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey.
Husain D; Kim I; Gauthier D; Lane AM; Tsilimbaris MK; Ezra E; Connolly EJ; Michaud N; Gragoudas ES; O'Neill CA; Beyer JC; Miller JW
Arch Ophthalmol; 2005 Apr; 123(4):509-16. PubMed ID: 15824225
[TBL] [Abstract][Full Text] [Related]
5. Intraocular properties of urokinase-derived antiangiogenic A6 peptide in rabbits.
Koh HJ; Cheng L; Bessho K; Jones TR; Davidson MC; Freeman WR
J Ocul Pharmacol Ther; 2004 Oct; 20(5):439-49. PubMed ID: 15650519
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of choroidal neovascularization by a peptide inhibitor of the urokinase plasminogen activator and receptor system in a mouse model.
Das A; Boyd N; Jones TR; Talarico N; McGuire PG
Arch Ophthalmol; 2004 Dec; 122(12):1844-9. PubMed ID: 15596589
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal infliximab and choroidal neovascularization in an animal model.
Olson JL; Courtney RJ; Mandava N
Arch Ophthalmol; 2007 Sep; 125(9):1221-4. PubMed ID: 17846362
[TBL] [Abstract][Full Text] [Related]
8. Relative contribution of VEGF and TNF-alpha in the cynomolgus laser-induced CNV model: comparing the efficacy of bevacizumab, adalimumab, and ESBA105.
Lichtlen P; Lam TT; Nork TM; Streit T; Urech DM
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4738-45. PubMed ID: 20393113
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization.
Tolentino MJ; Brucker AJ; Fosnot J; Ying GS; Wu IH; Malik G; Wan S; Reich SJ
Retina; 2004 Feb; 24(1):132-8. PubMed ID: 15076954
[TBL] [Abstract][Full Text] [Related]
10. Recombinant anti-vascular endothelial growth factor fusion protein efficiently suppresses choridal neovasularization in monkeys.
Zhang M; Zhang J; Yan M; Li H; Yang C; Yu D
Mol Vis; 2008 Jan; 14():37-49. PubMed ID: 18246030
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization.
Murata T; He S; Hangai M; Ishibashi T; Xi XP; Kim S; Hsueh WA; Ryan SJ; Law RE; Hinton DR
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2309-17. PubMed ID: 10892878
[TBL] [Abstract][Full Text] [Related]
12. The pharmacology study of a new recombinant human VEGF receptor-fc fusion protein on experimental choroidal neovascularization.
Zhang M; Yu D; Yang C; Xia Q; Li W; Liu B; Li H
Pharm Res; 2009 Jan; 26(1):204-10. PubMed ID: 18854954
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of the novel small-molecule integrin alpha5beta1 inhibitor JSM6427 in monkey and rabbit models of choroidal neovascularization.
Zahn G; Vossmeyer D; Stragies R; Wills M; Wong CG; Löffler KU; Adamis AP; Knolle J
Arch Ophthalmol; 2009 Oct; 127(10):1329-35. PubMed ID: 19822850
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects between intravitreal and periocular injections of adenoviral vectored pigment epithelium-derived factor on suppressing choroidal neovascularization in rats.
Yan H; Cui J; Wang Y; Yu Y
Ophthalmic Res; 2013; 49(2):81-9. PubMed ID: 23257710
[TBL] [Abstract][Full Text] [Related]
15. Optimization of laser-induced choroidal neovascularization in African green monkeys.
Goody RJ; Hu W; Shafiee A; Struharik M; Bartels S; López FJ; Lawrence MS
Exp Eye Res; 2011 Jun; 92(6):464-72. PubMed ID: 21414311
[TBL] [Abstract][Full Text] [Related]
16. Vascular Endothelial Growth Factor Receptor 2 Antibody, BC001, Attenuates Laser-Induced Choroidal Neovascularization in Rhesus Monkeys (Macaca mulatta).
Zhao T; Zhang J; Zhang Y; Huang J; Wang X; Zhang Y; Zhang M; Yuan Y; Xiao K; Li H; Zhong Z
J Ocul Pharmacol Ther; 2015 Dec; 31(10):611-6. PubMed ID: 26334588
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
Gu L; Chen H; Tuo J; Gao X; Chen L
Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
[TBL] [Abstract][Full Text] [Related]
19. Clinical and histological findings after intravitreal injection of bevacizumab (Avastin) in a porcine model of choroidal neovascularization.
Lassota N; Prause JU; Scherfig E; Kiilgaard JF; la Cour M
Acta Ophthalmol; 2010 May; 88(3):300-8. PubMed ID: 19416113
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal injection of (99)Tc-MDP inhibits the development of laser-induced choroidal neovascularization in rhesus monkeys.
Lai K; Jin C; Tu S; Xiong Y; Huang R; Ge J
Graefes Arch Clin Exp Ophthalmol; 2014 Jul; 252(7):1049-57. PubMed ID: 24390402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]